智通财经APP获悉，医渡科技(02158)尾盘涨超5%，截至发稿，涨5.24%，报6.43港元，成交额3658.84万港元。
消息面上，据IT新闻网报道，近日，由中国食品药品企业质量安全促进会指导，同写意主办的“T20+大会”在苏州召开，大会聚焦新药研发全链条创新，破解产业升级关键命题。国内AI医疗头部企业医渡科技携智能临床研究一体化解决方案亮相大会，系统呈现了AI驱动临床研究效率提升的可复制路径。据悉，目前医渡科技已服务超过350家国内外制药企业，积累了686个临床试验项目经验，前瞻性及回顾性真实世界研究项目达275项。
会上，医渡科技生命科学临床试验业务副总裁刘颖表示，多年来，医渡科技凭借积累的医疗大数据处理能力、疾病理解能力与疾病知识图谱构建优势，依托自主研发的“AI医疗大脑”YiduCore，构建起覆盖临床试验全流程的智能临床研究一体化解决方案。该解决方案在临床试验方案优化、患者智能招募、临床运营等药物研发关键环节大幅提速超30%，有效推动研发效率提升、产品上市路径优化及创新成本降低。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.